EUVIMEDEUVIMED entdecken
Crossref

Integrated Multi-Omics Analysis Reveals Cytokine Network Dynamics and Prognostic Signatures in Hepatitis B Virus-Associated Hepatocellular Carcinoma

Mo-Han Liu, Fu-Yong Zhang, Yuan-Jun Huang, Zhi-Hua Jiang, Qin-Yan Chen, Lu-Juan Zhang, Li-Ping Hu, Zhong-Liao Fang

Applied Biochemistry and Biotechnology · 2026

DOI: 10.1007/s12010-025-05528-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Applied Biochemistry and Biotechnology, 2026. Verfasst von Mo-Han Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Preclinical Medicine, Guangxi Medical University, 22 ShuangYong Road, Nanning, Guangxi, 530021, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Cytokines, Hepatitis B virus. Die Arbeit nennt 81 Literaturangaben. Gefördert von: The Natural Science Foundation of Guangxi.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hepatitis B virus-associated hepatocellular carcinoma (HBV-HCC) remains a major global health challenge due to late diagnosis and high tumor heterogeneity. Cytokines, as key mediators of the tumor microenvironment, contribute to immune evasion and tumor progression in HBV-HCC. However, their prognostic significance remains unclear. Bulk RNA sequencing revealed differentially expressed cytokine genes in HBV-HCC. A cytokine-based gene signature was created using the LASSO model, and Single-cell RNA sequencing analyzed gene expression at the cellular level. Serum and in vitro assays confirmed the key cytokine's role in tumor progression. Ten cytokine genes were differentially expressed in HBV-HCC, and six (CCL19, CCL20, CXCL2, GHR, IL1RAP, and LIFR) were selected to construct the LASSO-based risk model. This six-cytokine signature stratified patients into high- and low-risk groups with significantly different overall survival (P < 0.0001), achieving an area under the curve (AUC) exceeding 0.7 for 3-year survival in both training and validation cohorts. scRNA-seq revealed distinct cellular expression patterns of these cytokines, providing insights into their roles in tumor heterogeneity. High-risk patients exhibited enriched cell proliferation pathways and pronounced immunosuppression, whereas low-risk patients were associated with metabolic pathways. Drug sensitivity analysis identified 61 differentially responsive antitumor agents between risk groups. Notably, serum GHR levels increased during fibrosis but declined significantly in HBV-HCC. Functional assays demonstrated that GHR overexpression suppressed proliferation, migration, and invasion while promoting apoptosis. Our study integrates bulk and single-cell transcriptomics with functional validation, unveiling cytokine-driven mechanisms in HBV-HCC. The cytokine-based prognostic model holds promise for risk stratification, immunomodulation, and personalized therapy, offering new avenues for improving HBV-HCC management.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsCytokinesHepatitis B virusHepatitis BHumansMalePrognosisFemaleMiddle AgedGene Expression Regulation, NeoplasticMultiomics

Stichwörter der Autor:innen

Cytokine networkHepatitis b virusHepatocellular carcinomaPrognostic signaturesTumor microenvironment

Substanzen

Cytokines

Autor:innen und Institutionen

  • School of Preclinical Medicine, Guangxi Medical University, 22 ShuangYong Road, Nanning, Guangxi, 530021, China.
  • Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, Guangxi, 530028, China.
  • Key Laboratory of Clinical Laboratory Medicine of Guangxi Department of Education, Nanning, Guangxi, 530021, China.
  • Department of Clinical Laboratory, The First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, 530021, China.
  • Trauma Microsurgical Hand Surgery, Guangxi Zhuang Autonomous Region People's Hospital, Taoyuan Road 6, Nanning, Guangxi Zhuang Autonomous Region, 530021, China.
  • School of Preclinical Medicine, Guangxi Medical University, 22 ShuangYong Road, Nanning, Guangxi, 530021, China. zhongliaofang@hotmail.com.

Förderung

  • The Natural Science Foundation of Guangxi

Zitieren

APA

Liu, M. H., Zhang, F. Y., Huang, Y. J., Jiang, Z. H., Chen, Q. Y., Zhang, L. J., Hu, L. P., & Fang, Z. L. (2026). Integrated Multi-Omics Analysis Reveals Cytokine Network Dynamics and Prognostic Signatures in Hepatitis B Virus-Associated Hepatocellular Carcinoma. Applied Biochemistry and Biotechnology. https://doi.org/10.1007/s12010-025-05528-2

Vancouver

Liu MH, Zhang FY, Huang YJ, Jiang ZH, Chen QY, Zhang LJ, et al. Integrated Multi-Omics Analysis Reveals Cytokine Network Dynamics and Prognostic Signatures in Hepatitis B Virus-Associated Hepatocellular Carcinoma. Applied Biochemistry and Biotechnology. 2026. doi:10.1007/s12010-025-05528-2

BibTeX
@article{Liu2026,
  author = {Liu, Mo-Han and Zhang, Fu-Yong and Huang, Yuan-Jun and Jiang, Zhi-Hua and Chen, Qin-Yan and Zhang, Lu-Juan and Hu, Li-Ping and Fang, Zhong-Liao},
  title = {Integrated Multi-Omics Analysis Reveals Cytokine Network Dynamics and Prognostic Signatures in Hepatitis B Virus-Associated Hepatocellular Carcinoma},
  journal = {Applied Biochemistry and Biotechnology},
  year = {2026},
  doi = {10.1007/s12010-025-05528-2}
}
Kostenlos starten →